Trial
NCT01284335
A Safety Study in Participants With Advanced Solid Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Advanced Solid Tumors
Intervention
Gemcitabine
Why stopped
Study was terminated due to the termination of tasisulam development.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-10